5,5-Dimethyl-2-(4-methyl-1-naphthalenyl)-1,3,2-Dioxaborinane

Catalog No. :
ACNBYZ139
CAS No. :
1232309-74-8
Molecular Formula :
C16H19BO2
Molecular Weight :
254.14

IUPAC Name:5,5-dimethyl-2-(4-methylnaphthalen-1-yl)-1,3,2-dioxaborinane

5,5-Dimethyl-2-(4-methyl-1-naphthalenyl)-1,3,2-Dioxaborinane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00Login to see priceIn stockInquiry
1g95%$185.00Login to see priceIn stockInquiry
5g95%$650.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,5-Dimethyl-2-(4-methyl-1-naphthalenyl)-1,3,2-Dioxaborinane
IUPAC Name5,5-dimethyl-2-(4-methylnaphthalen-1-yl)-1,3,2-dioxaborinane
Molecular FormulaC16H19BO2
Molecular Weight254.14
SMILESCC1=C2C=CC=CC2=C(B3OCC(C)(C)CO3)C=C1
InChI KeyVQGCSABEVHTBQH-UHFFFAOYSA-N
Synonym5,5-dimethyl-2-(4-methylnaphthalen-1-yl)-1,3,2-dioxaborinane;5,5-dimethyl-2-(4-methyl-1-naphthalenyl)-1,3,2-Dioxaborinane;1,3,2-Dioxaborinane, 5,5-dimethyl-2-(4-methyl-1-naphthalenyl)-
CAS No.1232309-74-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACNBYZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNBYZ139 route product structure diagram
    ACNBYZ1391232309-74-8 In Stock
Inquiry

2. ACNBYZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDAV431 route compound structure diagram
    ACWDAV431201733-56-4 In Stock
  2. Plus
  3. ACKEJD243 route compound structure diagram
    ACKEJD2436627-78-7 In Stock
  4. Then
  5. ACNBYZ139 route product structure diagram
    ACNBYZ1391232309-74-8 In Stock
Inquiry

Comments (0)